Changes in the Use of Hydroxyprogesterone Caproate Injection After Confirmatory Trial Failure.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34870694.
- Also identified by DOI 10.1001/jamainternmed.2021.7001 and PMC identifier 8649909.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study examines changes in hydroxyprogesterone caproate fills from 2010 through 2020.
Medical subject headings
- Premature Birth
- Progestins